Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic LeukemiaPatrick A. Brown, Mignon L. Loh, Stephanie Terezakis et al.|JAMA|2021Cited by 358
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in <i>KMT2A</i>-rearranged leukemiaChangya Chen, Kai Tan, Wenbao Yu et al.|Blood|2021Cited by 113
rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosisSandeep Negi, Patrick A. Brown|Oncotarget|2015Cited by 96
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators’ Consortium study (POE 10‐03)Todd M. Cooper, Patrick A. Brown, Edward Allan R. Sison et al.|Pediatric Blood & Cancer|2017Cited by 73
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for childrenAndrew D.J. Pearson, Gilles Vassal, Kimberly Stegmaier et al.|European Journal of Cancer|2020Cited by 25